Neurobo Pharmaceuticals, Inc.
NRBO
Revenue
0.00
0.000.00%
-Assets
28.75M
▲11.73M▲68.94%
3 Months ChangeLiabilities
9.81M
▲2.87M▲41.30%
3 Months ChangeFree Cash Flow
-6.45M
▼-3.90M▼-152.72%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-07
Form 8-K
ID: 0001558370-24-013161
2024-09-30
Form 8-K
ID: 0001558370-24-013080
2024-09-19
Form 8-K
ID: 0001558370-24-012900
2024-08-14
Form 10-Q
ID: 0001558370-24-012272
2024-08-14
Form 8-K
ID: 0001558370-24-012137
2024-08-13
Form 8-K
ID: 0001558370-24-011984
2024-08-06
Form 8-K
ID: 0001558370-24-010964
2024-07-30
Form 8-K
ID: 0001558370-24-010321
2024-07-16
Form 8-K
ID: 0001558370-24-009827
2024-06-26
Form 8-K
ID: 0001558370-24-009490